Intrinsiqs

Is SpyGlass Pharma, Inc. Common Stock overvalued?

SpyGlass Pharma, Inc. Common Stock (SGP) — key valuation metrics and fundamentals.

No verdict
Price
$32.88
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.10B
Dividend yield
0.0%
Return on equity
-47.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SGP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.